Biogen Inc (BIIB)

BIIB (NASDAQ:Drugs) EQUITY
$318.78
pos +0.00
+0.00%
Today's Range: 312.70 - 322.35 | BIIB Avg Daily Volume: 1,892,700
Last Update: 07/31/15 - 3:59 PM EDT
Volume: 0
YTD Performance: -6.09%
Open: $0.00
Previous Close: $317.00
52 Week Range: $290.85 - $480.18
Oustanding Shares: 235,169,225
Market Cap: 74,548,644,325
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 10 11
Moderate Buy 2 2 2 2
Hold 9 8 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.93 1.88 1.82 1.77
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 21.40
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
21.40 21.50 25.63
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-14.75% -4.67% 118.60%
GROWTH 12 Mo 3 Yr CAGR
Revenue 46.50 0.92 0.24
Net Income 57.90 1.32 0.32
EPS 58.30 1.44 0.34
Earnings for BIIB:
EBITDA 3.41B
Revenue 8.51B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $3.92 $4.01 $15.92 $17.63
Number of Analysts 20 20 21 21
High Estimate $4.61 $4.53 $16.96 $19.85
Low Estimate $3.67 $3.76 $15.50 $16.20
Prior Year $3.79 $4.08 $13.79 $15.92
Growth Rate (Year over Year) 3.55% -1.80% 15.47% 10.70%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Aug 1, 2015 | 9:00 AM EDT

Jim Cramer, portfolio manager of Action Alerts PLUS, and research director Jack Mohr sat down to talk about their 'favorite company in the portfolio:' Allergan.

By

David Katz

 | Jul 30, 2015 | 11:00 AM EDT

Drugmaker has one of the best showings of earnings season.

By

David Katz

 | Jul 30, 2015 | 8:30 AM EDT

Drugmaker has one of the best showings of earnings season.

By

James "Rev Shark" DePorre

 | Jul 29, 2015 | 4:05 PM EDT

Oil- and commodity-related shares perform well.

By

Bret Jensen

 | Jul 29, 2015 | 7:39 AM EDT
I'm happy as always to be standing in for Doug Kass on the Daily Diary.
By

Dan Fitzpatrick

 | Jul 29, 2015 | 6:00 AM EDT

Three ways to profit after last Friday's crazy freefall.

By

Jim Cramer

 | Jul 27, 2015 | 4:00 PM EDT

Jim Cramer is watching Twitter (TWTR) as the social media giant releases earnings for its second quarter on Tuesday, July 28th after the market's closing bell.

By

Bret Jensen

 | Jul 27, 2015 | 1:00 PM EDT

This week could easily bring additional selling.

By

Jim Cramer

 | Jul 27, 2015 | 11:48 AM EDT

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

By

Helene Meisler

 | Jul 26, 2015 | 6:00 PM EDT

Its large drop made people take notice of the haves-have-nots divergence.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.